PhaseBio Pharmaceuticals (PHAS) null Earnings

13AugConfirmed
Aug 18
Oct 18
May 19
Aug 19
-10.45
-6.97
-3.48
0

Details

Expected EPS
-0.32
Actual EPS
-0.33
Surprise EPS
-0.01
Surprise Percent
+3.13%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -0.33 per share for .

0 Comments

Share your thoughts